… exists between SCLC cells and other cells in the body but it is unclear if these systemic
effects have a role in SCLC growth. Overall, the extent of the molecules secreted by SCLC …

… The International Association for the Study of Lung Cancer lung cancer staging project:
proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) …

… With its propensity for early hematogenous spread, SCLC is a systemic disease and is rarely
cured with surgical resection. Surgery alone is no longer used in the United States for SCLC…

… A pooled analysis showed that a positive family history of lung cancer predisposes
individuals to develop lung cancer 53 . Lung adenocarcinoma is more likely to have a genetic …

… Among patients with lung cancers, the proportion of those with small cell lung cancer (SCLC)
has decreased over the last decade. SCLC is staged as limited-stage disease and …

… In the decade since the last Lancet Seminar on lung cancer there have been advances in
many aspects of the classification, diagnosis, and treatment of non-small-cell lung cancer (…

… The benefits of early versus late radiation therapy were then verified by systematic review …
versus observation after at least a partial response to systemic chemotherapy [38]. As a caveat, …

… with oligometastatic non-small cell lung cancer (NSCLC) treated with locally ablative
therapies to all sites of metastatic disease. We performed a systematic review of the evidence for …

Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been
achieved over the past two decades, increasing our understanding of the disease biology …

… ) non-small cell lung cancer (NSCLC), but there have been no previously published systematic
reviews. Methods: A systematic review and meta-analysis of randomised controlled trials …